TNNI3 Gene Cardiomyopathy Dilated Type 2A NGS Genetic DNA Test
Comprehensive Genetic Testing for Inherited Heart Conditions
The TNNI3 Gene Cardiomyopathy Dilated Type 2A NGS Genetic DNA Test represents a breakthrough in cardiac genetic diagnostics, offering precise detection of mutations associated with dilated cardiomyopathy. This advanced testing methodology provides crucial information for individuals and families affected by inherited heart conditions, enabling early intervention and personalized treatment strategies.
What Does This Test Measure?
This specialized genetic test specifically analyzes the TNNI3 gene, which encodes cardiac troponin I – a critical protein component of the heart muscle’s contractile apparatus. The test utilizes Next-Generation Sequencing (NGS) technology to identify:
- Pathogenic mutations in the TNNI3 gene associated with dilated cardiomyopathy type 2A
- Genetic variations that disrupt normal cardiac muscle function
- Inherited patterns of cardiomyopathy risk within families
- Specific nucleotide changes affecting troponin I protein structure
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Unexplained heart failure symptoms at a young age
- Family history of dilated cardiomyopathy or sudden cardiac death
- Abnormal echocardiogram results showing enlarged heart chambers
- Progressive shortness of breath and exercise intolerance
- Palpitations or arrhythmias without clear cause
- Planning pregnancy with family history of cardiac conditions
Clinical Benefits of Genetic Testing
Undergoing the TNNI3 genetic test provides numerous advantages for patients and healthcare providers:
- Early Risk Identification: Detect genetic predisposition before symptoms develop
- Personalized Treatment: Tailor medication and lifestyle interventions based on genetic profile
- Family Screening: Identify at-risk relatives for proactive monitoring
- Reproductive Planning: Make informed decisions about family planning
- Peace of Mind: Reduce uncertainty about inherited cardiac conditions
Understanding Your Test Results
Our comprehensive genetic counseling services ensure you fully understand your test results:
- Positive Result: Indicates presence of a TNNI3 mutation associated with cardiomyopathy risk. Requires regular cardiac monitoring and potential preventive treatments.
- Negative Result: No disease-causing mutations detected in the TNNI3 gene, though continued cardiac health monitoring is still recommended.
- Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring ongoing research and monitoring.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art genetic testing facilities ensure consistent, reliable results regardless of your location.
Take Control of Your Cardiac Health Today
Don’t wait to address potential inherited cardiac risks. Our team of genetic counselors and cardiac specialists are ready to guide you through the testing process and help interpret your results. Early detection through genetic testing can significantly impact treatment outcomes and quality of life.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your TNNI3 Gene Cardiomyopathy Dilated Type 2A NGS Genetic DNA Test and take the first step toward comprehensive cardiac health management.
Note: Test results are typically available within 3-4 weeks. Sample collection options include blood draw, extracted DNA, or one drop of blood on FTA card. Pre-test genetic counseling and clinical history assessment are required components of our comprehensive testing protocol.
